Department of Respiratory Medicine, Level 1, Centre for Medical Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
Respir Care. 2010 Jun;55(6):702-6.
Mediastinal and hilar lymph node evaluation with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is being performed with increasing frequency. Original reports described performance under general anesthesia. Patient satisfaction is an important determinant of whether EBUS-TBNA may be performed under conscious sedation.
Consecutive patients undergoing EBUS-TBNA under conscious sedation completed a self-administered questionnaire 2-4 hours after the procedure. Satisfaction was determined by patient willingness to return for the procedure in the future. Patients also reported degree of recall of the procedure and any distressing symptoms. Procedural data and complications were also recorded.
Forty-one patients underwent EBUS-TBNA, with no serious complications. The mean dose of topical airway anesthesia was 332 +/- 51 mg lignocaine. The combinations and doses of intravenous sedative agents varied widely. Patient satisfaction was extremely high, with 40 patients (98%) reporting they would "definitely return" for EBUS-TBNA in the future if required, and one patient (2%) reporting he would "probably" return for such a procedure. To our knowledge, this is the highest reported patient satisfaction associated with a bronchoscopic procedure.
EBUS-TBNA may safely be performed under conscious intravenous sedation and is associated with very high patient satisfaction.
经支气管内超声引导针吸活检术(EBUS-TBNA)用于纵隔和肺门淋巴结评估的频率越来越高。最初的报告描述了在全身麻醉下进行的操作。患者满意度是决定 EBUS-TBNA 是否可以在清醒镇静下进行的重要因素。
在清醒镇静下接受 EBUS-TBNA 的连续患者在手术后 2-4 小时内完成了自我管理的问卷。满意度由患者是否愿意将来再次接受该手术来确定。患者还报告了对手术的记忆程度和任何令人痛苦的症状。还记录了手术过程数据和并发症。
41 例患者接受了 EBUS-TBNA,无严重并发症。局部气道麻醉的平均剂量为 332+/-51mg 利多卡因。静脉镇静剂的组合和剂量差异很大。患者满意度极高,40 名患者(98%)报告说,如果需要,他们“肯定会”再次接受 EBUS-TBNA,1 名患者(2%)报告说他“可能会”再次接受此类手术。据我们所知,这是与支气管镜检查相关的最高报道的患者满意度。
EBUS-TBNA 可在清醒静脉镇静下安全进行,且患者满意度非常高。